NOMURA HOLDINGS INC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
NOMURA HOLDINGS INC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$962,593
-46.6%
211,559
-17.4%
0.00%
-40.0%
Q2 2023$1,802,655
-20.5%
256,059
-31.0%
0.01%
-28.6%
Q1 2023$2,267,170
+34898.0%
371,059
-63.5%
0.01%
-73.1%
Q4 2022$6,478
-99.9%
1,015,738
+3.5%
0.03%
-31.6%
Q3 2022$9,405,000
-64.3%
981,284
-57.3%
0.04%
-17.4%
Q2 2022$26,340,000
+6831.6%
2,298,802
+19056.7%
0.05%
+4500.0%
Q1 2021$380,000
+38.2%
12,000
+20.0%
0.00%0.0%
Q2 2020$275,000
-69.1%
10,000
-89.1%
0.00%
-75.0%
Q1 2019$891,000
+65.6%
91,392
+50.1%
0.00%
+100.0%
Q4 2018$538,00060,8800.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders